News and Media

Tchaikapharma High Quality Medicines AD (BSE: 7TH) intends to build a third manufacturing plant in the village of Kazichene near Sofia. This became clear from documents published in the Commercial Register in connection with the forthcoming general meeting of shareholders, scheduled for June 22, 2020.   The investment is scheduled to be completed by the […]

President Trump takes hydroxychloroquine to prevent coronavirus infection even though it’s an unproven treatment   Professor Toni Vekov in an interview with NOVA: Tchaikapharma R&D Team worked around the clock to develop our own dossier   Within the next ten days, Tchaikapharma will produce about 5,000 packs of MoriVir (hydroxychloroquine), and in another week, at […]

Within a couple of days, Tchaikapharma is about to produce the first 5,000 MoriVir (hydroxychloroquin) packs for the front-line hospitals in the battle against COVID-19, and in May, another 20,000 GraVir (chloroquine) packs for further hospital treatment. “From May onwards, we expect a regular production, but it all depends on access to substances, which is […]

Tchaikapharma High Quality Medicines received a thank-you letter from Prof. Diana Ivanova, Ph.D., Dean of the Pharmacy Faculty at the Varna Medical University in connection with the “empathy and friendly support”, which the company traditionally attests to graduates in Pharmacy. 54 young pharmacists graduated at this year’s graduation ceremony 2019.   The original letter is […]

In 2019 Tchaikapharma (BSE:7TH) affirmed its leadership through successful development of scientific projects based on the advanced research on the development and integration of innovative combo medicines, some of which never used before in the global medical practice. Series of laboratory research and clinical studies are conducted in collaboration with European and American companies, namely […]